Doctor profile · Federal record
Dr. Matthew Devane, DO
Cardiovascular Disease Physician (CMS: Cardiovascular Disease (Cardiology)) · Walnut Creek, CA
- NPI 1770511040
- Accepts Medicare
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
106 la Casa Via, #140
Walnut Creek, CA 945983086
(925) 274-2860
fax (925) 932-4527 - Additional location
-
1450 Treat Blvd # 220B
Walnut Creek, CA 945972168
(925) 937-1700
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- November 7, 2022
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- California #20A7765
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770511040. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,888
Distinct HCPCS
10
Medicare allowed
$557,874
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,070 | 624 | $149 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 854 | 728 | $9 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 533 | 459 | $17 | |
J2785 |
Injection, regadenoson, 0.1 mg | 384 | 96 | $50 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 319 | 61 | $90 | |
93297 |
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 310 | 58 | $29 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 253 | 243 | $250 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 206 | 202 | $77 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 206 | 103 | $110 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 157 | 157 | $193 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 138. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$1,733
Transactions
66
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $281.19 | |
| Novo Nordisk Inc | 6 | $212.85 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $181.53 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $134.63 | |
| Amgen Inc. | 4 | $107.79 | |
| Janssen Pharmaceuticals, Inc | 6 | $105.92 | |
| Philips North America LLC | 3 | $94.85 | |
| Boston Scientific Corporation | 3 | $91.52 | |
| Esperion Therapeutics, Inc. | 4 | $89.14 | |
| AstraZeneca Pharmaceuticals LP | 4 | $61.02 | |
| Abbott Laboratories | 2 | $49.65 | |
| HEARTFLOW, INC. | 2 | $48.96 | |
| Kiniksa Pharmaceuticals International, plc | 2 | $47.20 | |
| ATRICURE, INC. | 2 | $37.35 | |
| Merck Sharp & Dohme LLC | 2 | $37.01 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,082
Patients
1,120
Total drug cost
$939,332
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 491 | 149 | $713,463 |
| Rosuvastatin Calcium | Generic | 486 | 189 | $12,138 |
| Atorvastatin Calcium | Generic | 351 | 124 | $4,837 |
| Metoprolol Succinate | Generic | 288 | 106 | $5,684 |
| Amlodipine Besylate | Generic | 206 | 77 | $1,916 |
| Carvedilol | Generic | 192 | 60 | $2,460 |
| Olmesartan Medoxomil | Generic | 181 | 74 | $10,194 |
| Xarelto (Rivaroxaban) | Brand | 134 | 40 | $177,880 |
| Amiodarone Hcl | Generic | 123 | 47 | $3,973 |
| Furosemide | Generic | 122 | 44 | $775 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Devane's medical specialty?
Dr. Matthew Devane practices Cardiovascular Disease Physician in Walnut Creek, CA.
Where does Dr. Matthew Devane practice?
Dr. Matthew Devane practices at 106 la Casa Via, Walnut Creek, CA 945983086. Office phone: 9252742860.
What is Dr. Matthew Devane's NPI?
Dr. Matthew Devane's National Provider Identifier (NPI) is 1770511040, issued by NPPES.
Does Dr. Matthew Devane accept Medicare assignment?
Yes. Dr. Matthew Devane accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Devane commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS 93010); Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS 93000). Source: CMS Medicare Physician & Other Practitioners file.